Hillsdale Investment Management »

Supernus Pharmaceuticals shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.8M 104k 46.51
2025-03-31 $5.9k 180 32.75

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Bk Nova Cad (BNS)
Enerflex (EFXT)
Suncor Energy (SU)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
Agnico (AEM)
Cenovus Energy (CVE)
NVIDIA Corporation (NVDA)
Shopify Inc cl a (SHOP)
Apple (AAPL)
Barrick Mining Corp (B)

View all positions for Hillsdale Investment Management

Top funds holding Supernus Pharmaceuticals

BlackRock
Millennium Management
Vanguard Portfolio Management
Armistice Capital
Vanguard Capital Management
State Street Corporation
Dimensional Fund Advisors
Nomura Asset Management International
Geode Capital Management
Stephens Investment Management Group
Renaissance Technologies
Loomis, Sayles and
Citadel Advisors
Two Sigma Investments
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals